Webb29 mars 2024 · 11 Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan. 12 Clinical Research Center, National Hospital … Webb6 Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan. 7 Department of …
Did you know?
Webb14 apr. 2024 · AbstractPurpose:. We evaluated plasma cell-free DNA (cfDNA) and tissue-based sequencing concordance for comprehensive oncogenic driver detection in non–small cell lung cancer (NSCLC) using a large-scale prospective screening cohort (LC-SCRUM-Liquid).Experimental Design:. Blood samples were prospectively collected … Webb2 Kanagawa Children's Medical Center, Yokohama, Japan. 3 Cancer Survivorship Support Research Unit, Kanagawa Cancer Center Research Institute, 2-3-2, Nakao, …
Webb9 Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan. 10 Division of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. 11 Department of Surgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan. PMID: 26116477 DOI: … Webb2 apr. 2015 · 4 Department of Pathology, Kanagawa Cancer Center Hospital, 2-3-2 Nakao, Asahi-Ku, Yokohama, Kanagawa, 241-8515, Japan. [email protected]. 5 …
WebbAt the Kanagawa Cancer Center, a group of doctors specialized in various cancers and medical staff comprehensively work out treatment plans by considering the symptoms … Webb14 apr. 2024 · AbstractPurpose:. In the dose-expansion part of this open-label, phase I study, we explored the efficacy and safety of E7389-LF (liposomal formulation of eribulin) in Japanese patients with advanced gastric cancer.Patients and Methods:. Patients with advanced gastric cancer who had been previously treated with ≥2 lines of …
Webb19 jan. 2024 · 382 Background: Capecitabine is usually used for patients with curatively resected biliary tract cancer (BTC) in EU and US, but no clear survival benefit has been shown in phase III trials. S-1, an oral fluoropyrimidine derivative, has shown promising efficacy, with a mild toxicity profile, in patients with advanced BTC. The aim of this trial …
Webb3Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan. 4Department of Surgery, Gastrointestinal Center, Kyoto Katsura Hospital, Kyoto, Japan. 5Department of Gastrointestinal Cancer Center, Sano Hospital, Hyogo, Japan. 6Department of Medical Oncology, Osaki Citizen Hospital, Miyagi, Japan. edgar starns of baton rouge laWebbKanagawa Cancer Center - Asahi-ku, Yokohama; Yokohama City University Hospital - Kanazawa-ku, Yokohama; Yokohama City University Medical Center - Minami-ku, … edgars sea girtWebb19 jan. 2024 · 4Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan. 5Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. 6Department of Medical Oncology, Kyorin University … configure belkin wireless routerWebb1 Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ward, Yokohama, 241-8515 Kanagawa Japan. 2 Department of Hematology, Yokohama City University Medical Center, Yokohama, Kanagawa Japan. 3 Department of Hematology/Oncology, Yamato Municipal Hospital, Yamato, Kanagawa Japan. configure bigpond email in outlookWebb7 Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan. 8 Department of Gastrointestinal Surgery, Kanagawa Cancer … configure bgp easily with birdWebb13 apr. 2024 · Ethics Compliance. This study was approved by the Ethics Committee of Yokohama City University Medical Center (approval no. B220400040; 18 April 2024), Yokohama City University Hospital (approval no. B220300073; 18 April 2024), Yokohama Municipal Citizen’s Hospital (approval no. 21–03-03; 9 March 2024), Kanagawa … configure bind9 serverWebb23 juni 2024 · Participants received placebo matched to atezolizumab via IV infusion every 2 weeks in combination with nab-paclitaxel (125 mg/m^2) via IV infusion every week for 12 weeks, followed by placebo matched to atezolizumab every 2 weeks in combination with doxorubicin (60 mg/m^2) and cyclophosphamide (600 mg/m^2) every 2 weeks via IV … edgars sundae cake